Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the surge in pharma M&A in 2025, ACA ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

Jarez Holz says 2026 will be a strong year for biotech stocks. The Mizuho analyst explained why in a recent CNBC interview.

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher— here's why.

C4 Therapeutics Inc. (NASDAQ: CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, ...

According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...

A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...

As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...

Here’s what was behind the recent sale of a former San Rafael biotech facility, a Santa Rosa distiller’s cautiously bold sublease, a Santa Rosa eye treatment center relocation, a San Rafael ...

On the last trading day of 2025, Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several portfolio moves across ...

By importing foreign price controls for drugs, he’s compounding making Biden’s mistake.